Globe Life Hikes Full-Year Guidance Despite Q1 Earnings Miss; Shares Edge Higher

Guidance Hike Offsets Quarterly Miss

Globe Life reported first-quarter net operating income of $3.43 per diluted share, falling just short of the $3.46 consensus estimate. On a GAAP basis, the company earned $3.39 per share. Revenue for the period came in at $1 billion, significantly trailing the $1.56 billion anticipated by Wall Street.

Despite the top-line shortfall, management provided a robust outlook for the remainder of the year. The company increased its full-year 2026 earnings guidance to a range of $15.40 to $15.90 per share, up from previous projections. This $0.35 increase at the midpoint suggests that the insurer is seeing stronger-than-expected profitability in its core insurance operations, even if total revenue growth lagged in the first three months of the year.

Strong Underwriting and Divisional Growth

The quarter was defined by strong performance across Globe Life’s various insurance segments. Total life net sales grew by 6% year-over-year, with every division contributing to the expansion.

The Liberty National Division was a standout performer, posting a 13% increase in life net sales and an 11% rise in underwriting margin. Crucially for future growth, the division’s average producing agent count grew by 9%. Similarly, the Family Heritage Division saw health net sales jump 22%, supported by a 10% increase in its agent force.

In the United American Division, health net sales more than doubled, rising from $28 million to approximately $62 million. This divisional momentum helped push the company’s total insurance underwriting income to $352.4 million, an 11% increase on a per-share basis compared to the year-ago quarter.

Capital Allocation and Market Reaction

Globe Life remains aggressive in its capital return strategy. During the first quarter, the company repurchased 1.4 million shares of common stock at a total cost of $203 million. This buyback activity, combined with rising profitability, helped drive book value per share to $77.03, a 19% increase over the first quarter of 2025.

Investors reacted positively to the guidance hike and the underlying strength of the underwriting margins. In after-hours trading, Globe Life shares rose 0.51% to $152.01, building on a previous close of $151.25. The stock has been trading near its 52-week highs as the market prices in a recovery in mortality trends and the company's distribution advantage.

Analyst Perspective

Analysts at Morgan Stanley recently highlighted Globe Life as a preferred pick, noting that its valuation remains "abnormally low" relative to historical levels despite encouraging operational performance. Market sentiment has also been bolstered by normalizing mortality trends following the pandemic era, which analysts at Texas Capital Securities suggest could provide further upside to management’s already-raised guidance.

With a return on equity (ROE) of 17.9% for the quarter and double-digit growth in book value, Globe Life appears to be successfully navigating a complex macroeconomic environment by focusing on high-margin protection products for the underserved middle market.